BIOBIJOU Co.,Ltd.
Research BIOBIJOU Co.,Ltd. (489460.KQ) on Bullrun: market cap KRW 191.79B, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker489460.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyKRW
- Market capKRW 191.79B
- Dividend yield0.8%
- Financial periodQ2 2026
- RevenueKRW 9.88B
- Net incomeKRW 2.54B
- Free cash flowKRW 1.10B
- Gross margin41.6%
Valuation Snapshot
latest market cap is KRW 191.79B; dividend yield is 0.8%.
Peer valuation comparison
Latest dividend yield is 0.77% versus a Healthcare sector median of 2.4% (67.9% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 191.79B | n/a | 0.8% | 100 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 100 KRW, yield 0.8%.
About BIOBIJOU Co.,Ltd.
BIOBIJOU Co.,Ltd. engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea. It offers cosmetic products which includes skin boosters which is used in treatment to improve skin condition using microneedle therapy system; medical devices include hyaluronic acid dermal fillers under the COLENA PREMIUM and CANDORLOV brand name; and pharmaceuticals, such as include botulinum toxin.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BIOBIJOU Co.,Ltd.'s market cap?
BIOBIJOU Co.,Ltd.'s market capitalization is KRW 191.79B.
Does BIOBIJOU Co.,Ltd. pay a dividend?
BIOBIJOU Co.,Ltd. has a dividend yield of 0.8%.
What does BIOBIJOU Co.,Ltd. do?
BIOBIJOU Co.,Ltd. engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea. It offers cosmetic products which includes skin boosters which is used in treatment to improve skin condition using microneedle therapy system; medical devices include hyaluronic acid dermal fillers under the COLENA PREMIUM and CANDORLOV brand name; and pharmaceuticals, such as include botulinum toxin. It also exports its products to Iraq, the Dominican Republic, Turkey, China, Vietnam, Hong Kong, Russia, Malaysia, the United Kingdom, CIS, and Colombia.